Healthy Skepticism Library
Items published during the years 1990 to 1999
There are 2362 items in the Healthy Skepticism Library that were published during the years 1990 to 1999.
Page 7 of 24 pages ‹ First < 5 6 7 8 9 > Last ›
HSL6747
Vitry A, Mansfield P.
Re: breaches of the APMA Code of Conduct
1997 Jun;
HSL8186
Employer/employee relations committee
Carolina Journal of Pharmacy 1997 Jun-Aug; 77:6-7
HSL8233
Cohen MR.
Call for an end to unsafe abbreviations in journal ads
Hospital Pharmacy 1997 Jun; 32:835-836
HSL6744
Advertisements for donepezil (Aricept) in the BMJ [Editor's response]
BMJ 1997 May 24; 314:1556
http://bmj.com/cgi/content/full/314/7093/1555
HSL6745
Gray S.
Advertisements for donepezil (Aricept) in the BMJ: Advertisement suggests an unrealistic improvement in mental status
BMJ 1997 May 24; 314:1555
http://bmj.com/cgi/content/full/314/7093/1555
HSL6746
Wagner N.
Advertisements for donepezil (Aricept) in the BMJ: Local committee has declined to approve NHS hospital prescription of donepezil.
BMJ 1997 May 24; 314:(7093):1555-6
http://bmj.com/cgi/content/full/314/7093/1555
HSL556
Horton R.
Sponsorship, authorship, and a tale of two media.
Lancet 1997 May 17; 349:(9063):1411-2
HSL8324
Lisi DM.
Ethical issues for pharmacists in managed care.
Am J Health Syst Pharm 1997 May 1; 54:(9):1041-2,
http://www.ajhp.org/cgi/reprint/54/9/1041
HSL1894
Lexchin J.
What information do physicians receive from pharmaceutical representatives?
Can Fam Physician 1997 May; 43:941-5
HSL6738
Beaufour-Ipsen’s promotion of Smecta (smectite)
MaLAM International News 1997 May-Jun; 15:(5-6):1-2
HSL6739
Health and medical reporting: PMAC sponsored medical journalism program
PMAC News 1997 May-Jun; 6
HSL6740
MaLAM complaints to the APMA
MaLAM Australian News 1997 May-Jun; 5:(5-6):1
HSL6741
MaLAM letter follow up—Rhone Poulenc Rorer’s promotion of Flagyl (metronidazole)
MaLAM International News 1997 May-Jun; 15:(5-6):2
HSL6742
Program update
PMAC News 1997 May-Jun; 8-9
HSL6743
Servier resists but MaLAM persists!
MaLAM Australian News 1997 May-Jun; 5:(5-6):2
HSL8242
Janssen tops list of '96 nursing home sales leaders; Glaxo first in total US sales, Novartis first in global sales
Consultant Pharmacist 1997 May; 12:610
HSL19992
Derby RA, Peabody JW, Bickel SR, Lawson JS
Cost of drugs in Australia's pharmaceutical benefit scheme
JAMA 1997 Apr 23; 277:(16):1277
http://jama.ama-assn.org/content/277/16/1277.1.short
HSL529
Raveendran R, Gitanjali B.
Conflict of interest.
Lancet 1997 Apr 19; 349:(9059):1173-4
http://www.thelancet.com/search/results?search_searchuri=%2Fsearch%2Fadvanced&search_resulturi=%2Fsearch%2Fresults&search_preview=no&search_reqfirst=1&search_reqcount=20&search_submode=advanced&update_search=no&search_mode=platform&search_cluster=phoenix&search_text1=Raveendran+R+&search_within1=au&search_operator1=and&search_text2=Gitanjali+B&search_within2=au&search_operator2=and&search_text3=&search_within3=all&restrictterm_lancet=lancet&restrictname_lancet=lancet&restricttype_lancet=journal&restrictdesc_lancet=The+Lancet&restrictname_laneur=laneur&restricttype_laneur=journal&restrictdesc_laneur=The+Lancet+Neurology&restrictname_laninf=laninf&restricttype_laninf=journal&restrictdesc_laninf=The+Lancet+Infectious+Diseases&restrictname_lanonc=lanonc&restricttype_lanonc=journal&restrictdesc_lanonc=The+Lancet+Oncology&search_dateradio=combo&search_datecombo=0%3AALL&search_monthstartcombo=1&search_yearstart=1996&search_monthendcombo=1&search_yearend=2005&search_wordsexactly=yes&search_sort=relevance&Submit=Search
HSL537
McCarthy M.
Sponsors lose fight to stop thyroxine study publication.
Lancet 1997 Apr 19; 349:(9059):1149
http://www.thelancet.com/search/results?search_searchuri=%2Fsearch%2Fadvanced&search_resulturi=%2Fsearch%2Fresults&search_preview=no&search_reqfirst=1&search_reqcount=20&search_submode=advanced&update_search=no&search_mode=platform&search_cluster=phoenix&search_text1=McCarthy+M&search_within1=au&search_operator1=and&search_text2=Sponsors&search_within2=ti&search_operator2=and&search_text3=&search_within3=all&restrictterm_lancet=lancet&restrictname_lancet=lancet&restricttype_lancet=journal&restrictdesc_lancet=The+Lancet&restrictname_laneur=laneur&restricttype_laneur=journal&restrictdesc_laneur=The+Lancet+Neurology&restrictname_laninf=laninf&restricttype_laninf=journal&restrictdesc_laninf=The+Lancet+Infectious+Diseases&restrictname_lanonc=lanonc&restricttype_lanonc=journal&restrictdesc_lanonc=The+Lancet+Oncology&search_dateradio=combo&search_datecombo=0%3AALL&search_monthstartcombo=1&search_yearstart=1997&search_monthendcombo=12&search_yearend=1997&search_wordsexactly=yes&search_sort=relevance&Submit=Search
HSL555
Horton R.
Conflicts of interest in clinical research: opprobrium or obsession?
Lancet 1997 Apr 19; 349:(9059):1112-3
HSL8245
Kay A.
State of the art. Part 1. Generic medicines
Pharmaceutical Journal 1997 Apr 19; 258:554-559
HSL569
Deyo RA, Psaty BM, Simon G, Wagner EH, Omenn GS.
The messenger under attack -- intimidation of researchers by special-interest groups.
N Engl J Med 1997 Apr 17; 336:(16):1176-80
HSL527
Rennie D.
Thyroid storm.
JAMA 1997 Apr 16; 277:(15):1238-43
HSL565
Eckert CH.
Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom.
JAMA 1997 Apr 16; 277:(15):1200-1
HSL568
Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, Greenspan FS.
Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
JAMA 1997 Apr 16; 277:(15):1205-13
HSL575
Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS.
Withholding research results in academic life science. Evidence from a national survey of faculty
JAMA. 1997 Apr 16; 277:(15):1224-8
HSL20393
Shaughnessy AF
Patient-Oriented Evidence That Matters: POEMS
EJHP 1997 Apr 15; 126:(8):667
http://www.google.com.au/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CCcQFjAA&url=http%3A%2F%2Fwww.essentialevidenceplus.com%2Farticles%2FEJHP_Feb04p64.pdf&ei=bHh-UMetBI2zrAel54CABA&usg=AFQjCNHxJWkt04BVh5TJgARYiYn9ZjDd-w
HSL530
Rapp MS.
Can drug companies have it both ways?
CMAJ 1997 Apr 1; 156:(7):982-3
http://www.cmaj.ca/cgi/reprint/156/7/982
HSL6720
Lexchin J.
Consequences of direct-to-consumer advertising of prescription drugs.
Can Fam Physician 1997 Apr; 43:594-6,:
HSL8244
Wechsler J.
Who's going to pick up FDA's user fee tab?
Managed Healthcare 1997 Apr; 7:17
HSL8246
Southwick K.
Battling allergy therapies focus on consumer choice
Managed Healthcare 1997 Apr; 7:54-58
HSL8326
Wechsler J.
Washington report: Congress debates FDA fees and funding
Pharmaceutical Technology 1997 Apr; 21:16, 18, 20, 22, 24, 26, 28
HSL19799
Stix G
The Ties That Bind: A study of journal publications details investigators' financial interests in their research
Scientific American 1997 Mar 17
http://www.scientificamerican.com/article.cfm?id=the-ties-that-bind
HSL515
Sukkari SR.
Weighing benefits and risks of drug to treat obesity.
CMAJ 1997 Mar 15; 156:(6):768-9
http://www.cmaj.ca/cgi/reprint/156/6/768
HSL551
Judge R.
Dangers of fluoxetine.
Lancet 1997 Mar 15; 349:(9054):809
HSL516
Stone LR.
Editorials and conflicts of interest.
N Engl J Med 1997 Mar 6; 336:(10):728
http://content.nejm.org/cgi/search?andorexactfulltext=and&andorexacttitleabs=and&excludeflag=TWEEK_element&search_tab=authors&searchtitle=Authors&hits=20&author1=Stone+LR&sendit=GO&author2=&fulltext=&sortspec=Score+desc+PUBDATE_SORTDATE+desc&fmonth=Aug&fyear=1995&tmonth=Aug&tyear=2005&tocsectionid=Original+Articles&tocsectionid=Special+Reports&tocsectionid=Special+Articles&tocsectionid=Images+in+Clinical+Medicine&tocsectionid=Clinical+Practice&tocsectionid=Case+Records+of+the+Massachusetts+General+Hospital&tocsectionid=Review+ArticlesAORBClinical+PracticeAORBClinical+Implications+of+Basic+ResearchAORBMolecular+Medicine&tocsectionid=Clinical+Problem-Solving&tocsectionid=EditorialsAORBPerspectiveAORBOutlookAORBBehind+the+Research&tocsectionid=Legal+Issues+in+Medicine&tocsectionid=Sounding+BoardAORBClinical+Debate&tocsectionid=Correspondence&tocsectionid=Clinical+Implications+of+Basic+Research&tocsectionid=Book+Reviews&tocsectionid=Health+Policy*AORBQuality+of+Health+Care&tocsectionid=Occasional+Notes
HSL526
Salzman R.
Editorials and conflicts of interest.
N Engl J Med 1997 Mar 6; 336:(10):728
http://content.nejm.org/cgi/search?andorexactfulltext=and&andorexacttitleabs=and&excludeflag=TWEEK_element&search_tab=authors&searchtitle=Authors&hits=20&author1=Salzman+R&sendit=GO&author2=&fulltext=&sortspec=Score+desc+PUBDATE_SORTDATE+desc&fmonth=Feb&fyear=1997&tmonth=Apr&tyear=1997&tocsectionid=Original+Articles&tocsectionid=Special+Reports&tocsectionid=Special+Articles&tocsectionid=Images+in+Clinical+Medicine&tocsectionid=Clinical+Practice&tocsectionid=Case+Records+of+the+Massachusetts+General+Hospital&tocsectionid=Review+ArticlesAORBClinical+PracticeAORBClinical+Implications+of+Basic+ResearchAORBMolecular+Medicine&tocsectionid=Clinical+Problem-Solving&tocsectionid=EditorialsAORBPerspectiveAORBOutlookAORBBehind+the+Research&tocsectionid=Legal+Issues+in+Medicine&tocsectionid=Sounding+BoardAORBClinical+Debate&tocsectionid=Correspondence&tocsectionid=Clinical+Implications+of+Basic+Research&tocsectionid=Book+Reviews&tocsectionid=Health+Policy*AORBQuality+of+Health+Care&tocsectionid=Occasional+Notes
HSL567
Douglas EF.
Editorials and conflicts of interest.
N Engl J Med 1997 Mar 6; 336:(10):728
HSL576
Blank NK.
Editorials and conflicts of interest.
N Engl J Med 1997 Mar 6; 336:(10):728-9
HSL559
Heagerty AM.
Industry-sponsored research.
Lancet 1997 Mar 1; 349:(9052):588
HSL5336
Guell RC.
Haggling for a patent: what a government would have to pay for prescription drug patents.
Health Econ 1997 Mar-Apr 01; 6:(2):179-85
http://www3.interscience.wiley.com/cgi-bin/abstract/14638/ABSTRACT
HSL392
Lexchin J.
[Pharmaceutic regulation and inadequate drug prescription in Canada: the case of psychotropic drugs in the 1960s and early 1970s]
Sante Ment Que. 1997 Spring; 22:(1):283-300
HSL6728
Sacristan JA, Bolanos E, Hernandez JM, Soto J, Galende I.
Publication bias in health economic studies.
Pharmacoeconomics 1997 Mar; 11:(3):289-92
HSL6735
APMA’s revised Code still inadequate
MaLAM Australian News 1997 Mar-Apr; 5:(3-4):1-4
HSL6736
Knowledge is the best medicine: campaign update
PMAC News 1997 Mar-Apr; 5-6
HSL8232
Poovala S, Banahan B, Kolassa M.
Marketing smart: what makes your MCO tick?
Pharmaceutical Executive 1997 Mar; 17:54-56, 58, 60, 62
HSL6734
Avoid financial 'correctness'.
Nature. 1997 Feb 6; 385:(6616):469
HSL522
Shapiro MF.
Regulating pharmaceutical advertising: what will work?
CMAJ 1997 Feb 1; 156:(3):359-61
http://www.cmaj.ca/cgi/reprint/156/3/359
HSL547
Lexchin J.
Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines?
CMAJ 1997 Feb 1; 156:(3):351-6
http://www.cmaj.ca/cgi/reprint/156/3/351
HSL570
Desjardins JG.
The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada
CMAJ 1997 Feb 01; 156:(3):363-4
HSL8335
Earl-Slater A.
Regulating the price of the UK's drugs: second thoughts after the government's first report.
BMJ 1997 Feb 1; 314:(7077):365-8
http://www.bmj.com/cgi/content/full/314/7077/365
HSL8323
Asplen L.
ASHP helping members comply with R Ph information plan
Hospital Pharmacist Report 1997 Feb; 11:1, 8
HSL6733
Applegate WB, Furberg CD, Byington RP, Grimm R Jr.
The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)
JAMA 1997 Jan 22-29; 277:(4):297
HSL19760
Wright M
1-800: is anyone listening? A prescription for effective pharmaceutical database marketing
Strategy 1997 Jan 20
www.strategyonline.ca/1997/01/20/19393-19970120/#ixzz1jOv04eau
HSL574
Bourguignon RP.
Dangers of fluoxetine.
Lancet 1997 Jan 18; 349:(9046):214
HSL20467
Durand de Bousingen D
Growth-hormone CJD scandal rocks France
The Lancet 1997 Jan 18; 349:(9046):189
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2805%2960939-7/fulltext#article_upsell
HSL8336
Bhutta TI, Vitry A.
Treating dysentery with metronidazole in Pakistan.
BMJ 1997 Jan 11; 314:(7074):146-7
HSL20468
Ed.
And now all this
The Lancet 1997 Jan 4; 349:(9044):1
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2897%2921001-9/fulltext
HSL550
Lal A, Moharana AK, Srivastava S.
Comparative evaluation of drug advertisements in Indian, British and American medical journals.
J Indian Med Assoc 1997 Jan; 95:(1):19-20
HSL561
Herman AA, McCarthy BJ, Bakewell JM, Ward RH, Mueller BA, Maconochie NE, Read AW, Zadka P, Skjaerven R.
Data linkage methods used in maternally-linked birth and infant death surveillance data sets from the United States (Georgia, Missouri, Utah and Washington State), Israel, Norway, Scotland and Western Australia.
Paediatr Perinat Epidemiol 1997 Jan; 11:
http://www.bmj.com/cgi/content/full/315/7106/480
HSL573
Bradley LR, Zito JM.
Direct-to-consumer prescription drug advertising.
Med Care 1997 Jan; 35:(1):86-9
HSL6730
Follow-up: Boehringer Ingelheim’s promotion of Catovit (Prolintane)
MaLAM Australian News 1997 Jan-Feb; 5:(1-2):3
HSL6731
Follow-up: Whitehall’s promotion of Robitussin (dextromethorphan and/or guaiphenesin and/or pseudoephedrine)
MaLAM Australian News 1997 Jan-Feb; 5:(1-2):4
HSL6732
Inappropriate drug promotion in developed and developing countries: two sides of the same coin
MaLAM Australian News 1997 Jan-Feb; 5:(1-2):1-2
HSL8226
Andrews EB; ISPE.
The re-emergence of epidemiology within the pharmaceutical industry.
Pharmacoepidemiol Drug Saf 1997 Jan; 6:(1):57-9
HSL8332
Wechsler J.
Washington report: new year promises new initiatives, new FDA commissioner
Pharmaceutical Technology 1997 Jan; 21:16, 18, 20, 22, 24, 26
HSL8333
FDA is meeting the performance goals of the Prescription Drug User Fee Act
Pharmaceutical Technology 1997 Jan; 21:40
HSL520
Shear NH, Black F, Lexchin J.
Physician-detailer interaction—II.
Can J Clin Pharmacol 1997; 4:(1):10
HSL524
Sanders HD.
Physician-detailer interaction—I.
Can J Clin Pharmacol 1997; 4:(1):9
HSL528
Reid T.
Onsert with Canadian Family Physician questionable.
Canadian Family Physician 1997; 43:613
HSL531
Quinn J, Nangle M, Casey PR.
Analysis of psychotropic drug advertising
Psychiatric Bulletin 1997; 21:597-99
HSL533
Ollila E, Hemminki E.
Does licensing of drugs in industrialized countries guarantee drug quality and safety for Third World countries?
International Journal of Health Services 1997; 27:309-328
HSL538
Mansfield P, Lexchin J.
MaLAM: networking for scientific integrity in drug promotion.
Essential Drugs Monitor 1997(24):5
http://web.archive.org/web/20080511183432/http://healthyskepticism.org/library/EDM/24/Page5.pdf
HSL539
Mansfield P.
Can health professionals lobby drug companies to upgrade from misleading promotion to reliable service?
Australian Prescriber 1997; 20:(Supp 1):150
HSL542
Maddox LM, Katsanis LP.
Direct-to-consumer advertising of prescription drugs in Canada: its potential effect on patient-physician interaction.
Journal of Pharmaceutical Marketing & Management 1997; 12:(1):1-21
HSL543
MacKowiak ED, O'Connor TW, Geller H, Nguyen J, Wilkes W.
A survey of pharmacists' and pharmacy students' attitudes toward OTC advertising
Journal of Pharmaceutical Marketing & Management 1997; 12:(1):33-49
HSL546
Lexchin J.
Recent progress in drug advertising
Can Fam Physician 1997; 43:1041-1042
HSL552
Jeffries JJ.
Physician-detailer interaction—II.
Can J Clin Pharmacol 1997; 43:(1):10
HSL553
Additional statements from the International Committee of Medical Journal Editors.
CMAJ 1997; 156:(4):571-8
http://www.cma.ca/cmaj/vol-156/issue-4/0571.htm
HSL578
Ault A.
Further controversial provisions in the bill
Lancet 1997; 350:1690
HSL581
Wolfe S.
Drug advertisements and prescribing
Lancet 1997; 348:1452-1453
HSL1604
Suryawati S, Santoso B.
Drug advertisements: A critical lesson for Indonesian students
Essential Drugs Monitor 1997; 23:23
http://www.who.int/medicines/library/monitor/edm_23_e.pdf
HSL2105
Bischoff MB.
Successful pharmaceutical selling: Frank advice from the front lines.
New York: McGraw Hill 1997
http://www.amazon.com/exec/obidos/tg/detail/-/0786312114/qid=1124508662/sr=1-1/ref=sr_1_1/002-4340062-2313626?v=glance&s=books
HSL5427
Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW.
Methods for the Economic Evaluation of Health Care Programs
Oxford: Oxford University Press 1997
HSL6711
CMA sets rules for sale of prescribing data
Canadian Medical Association Journal 1997; 156:155
http://www.cma.ca/cmaj/vol-156/issue-2/0155a.htm
HSL6712
Angell M, Kassirer JP.
Editorials and conflicts of interest
New England Journal of Medicine 1997; 336:729
HSL6713
Davis P.
Managing medicines: public policy and therapeutic drugs
Buckingham, United Kingdom: Open University Press 1997
HSL6714
Erisman MD.
Editorials and conflicts of interest
New England Journal of Medicine 1997; 336:729
HSL6715
Feczko JM.
Pfizer night at Boston Billiards
New England Journal of Medicine 1997; 337:134
HSL6716
Gordon DA.
Intimidation of researchers by special-interest groups
New England Journal of Medicine 1997; 337:1316-1317
HSL6718
Kamat VR, Nichter M.
Monitoring product movement: an ethnographic study of pharmaceutical sales representatives in Bombay, India
ABIM - An Annotated Bibliography of Indian Medicine London: Zed Books 1997
http://indianmedicine.eldoc.ub.rug.nl/root/K/55269/
HSL6719
Kiatying-angsulee N.
A participatory evaluation of the implementation of the WHO ethical criteria for medicinal drug promotion in multiple countries
Australian Prescriber 1997; 20:(Supplement 1):151
www.australianprescriber.com
HSL6721
Lucas PN
Education and information: obligations and responsibilities to health care professionals and to consumers: A decade of achievement: 1996-1997 annual report
Ottawa: Pharmaceutical Manufacturers Association of Canada 1997
HSL6722
Martin JB.
Bioequivalence of levothyroxine preparations: industry sponsorship and academic freedom
JAMA 1997; 277:1201
HSL6723
Molloy W, Strang DG, Wadhwa SG, Carter PA
The fine detail
Troy, Ontario, Canada: Newgrange Press 1997
HSL6724
Mongeau JG.
Weighing benefits and risks of drug to treat obesity
Canadian Medical Association Journal 1997; 156:769
HSL6725
Phillips D, Marlow B.
Response to onsert
Canadian Family Physician 1997; 43:1205
HSL6727
Rogers A.
EU has limited power to curb Internet drug sales
Lancet 1997; 349:1895
HSL6729
Whiteside C.
Onsert with Canadian Family Physician questionable
Canadian Family Physician 1997; 43:613
HSL6737
Martin J.
Condition: confused. Why medical reporting suffers from actue ignorance, massive hysteria and intensive carelessness
Ryerson Review of Journalism 1997; 44-51
www.ryerson.ca/uacollection/dept/comrel/rrj/
Page 7 of 24 pages ‹ First < 5 6 7 8 9 > Last ›
